AMBR INSTITUTE AS
Ambr Institute builds highly accurate disease risk predictions using AI and multi-omic biomarkers, integrating diverse biological and clinical data to deliver holistic, data-driven insights for improved healthcare and prevention.
About AMBR INSTITUTE AS
Ambr Institute is an AI-powered clinical platform using multi-omic biomarkers and explainable AI to deliver rapid, accurate disease risk predictions. Trained on 600,000 patients, it enables physicians to identify, stratify and act on chronic conditions cardiovascular, metabolic, and neurological in seconds. Its digital twin technology integrates genetic, epigenetic, biomarker, lifestyle and clinical data to simulate long-term health outcomes and intervention effects. By combining transparent reasoning with real-time predictive insights, Ambr transforms preventive medicine into proactive, data-driven care, improving clinical decision-making and patient outcomes. Founded in 2022.
Revenue Stream
SubscriptionAbout Funding
External Funding Ambr's external funding strategy combines deep-tech backing from Intellectual Labs and non-dilutive Eurostars grants with a partially closed €1.8M Seed round to heavily de-risk the company for incoming venture capital.Recently Added Startups
QUIN
getquin is a digital wealth platform founded in 2020, helping users manage all assets in one place. It provides portfolio analytics and insights to support smarter, data-driven financial decisions.
AMBR INSTITUTE AS
Ambr Institute builds highly accurate disease risk predictions using AI and multi-omic biomarkers, integrating diverse biological and clinical data to deliver holistic, data-driven insights for improved healthcare and prevention.
ORBID
ORBID is a network-native matchmaking platform for Solar and BESS projects, connecting expertise and demand, streamlining decisions, and unifying the entire service chain into one digital platform. Founded in 2025.
Related Post
Montpellier-based SeqOne Acquires Cambridge-based Congenica
TRIMTECH funding news – Cambridge-based TRIMTECH Therapeutics €28.6 Million in Seed Funding
52North funding news – Cambridge-based 52North has Raised €5.7 Million in Funding
Biotech
AMBR INSTITUTE AS
Ambr Institute builds highly accurate disease risk predictions using AI and multi-omic biomarkers, integrating diverse biological and clinical data to deliver holistic, data-driven insights for improved healthcare and prevention.
Catalym
CatalYm GmbH develops innovative immunotherapies that activate the body’s immune system to fight cancer, aiming to improve treatment outcomes and transform the lives of patients worldwide.
Norway
AMBR INSTITUTE AS
Ambr Institute builds highly accurate disease risk predictions using AI and multi-omic biomarkers, integrating diverse biological and clinical data to deliver holistic, data-driven insights for improved healthcare and prevention.
PortalOne
PortalOne, Inc. is the world’s first hybrid games platform, combining elements of traditional gaming and interactive live experiences to create a unique, immersive gaming experience for players.
Oslo
AMBR INSTITUTE AS
Ambr Institute builds highly accurate disease risk predictions using AI and multi-omic biomarkers, integrating diverse biological and clinical data to deliver holistic, data-driven insights for improved healthcare and prevention.
PortalOne
PortalOne, Inc. is the world’s first hybrid games platform, combining elements of traditional gaming and interactive live experiences to create a unique, immersive gaming experience for players.